Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nesina Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Sulfonylurea

NCT01964950 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT01964950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01964950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nesina Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Sulfonylurea
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
July 31, 2011
Completion date
December 31, 2014
Enrollment
1,101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

surveillance